Skip to content
DataLookout
Menu

PIProBaTo-IINCT07893301

The Impact of Postbiotic Supplementation on Tolerability and Physiological/Metabolic Parameters

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

Version history last read from ClinicalTrials.gov on Oct 24, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.

All 1 version: 1 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Change in Gastrointestinal Symptom Rating Scale (GSRS) Score
Timeframe: Baseline (T0) and Week 12 (T1)

Secondary (18)

Change in Gastrointestinal Quality of Life Index (GIQLI) Total Score
Change in Pittsburgh Sleep Quality Index (PSQI) Global Score
Change in Dietary Intake and Ultra-Processed Foods Consumption
Change in Body Composition Assessed by Bioelectrical Impedance Analysis
Change in Skin Autofluorescence (SAF)
Show 13 moreShow less
Change in Gut Microbiome Composition and Function
Change in Blood Biochemical Profile
Change in Fasting Insulin Levels
Change in Testosterone Levels
Change in Estradiol Levels
Change in Sex Hormone-Binding Globulin (SHBG) Levels
Change in Inflammatory Cytokine Profile
Change in Incretin Profile
Change in Serum Zonulin Levels
Change in Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels
Change in Plasma N-Acylethanolamine Profile
Change in Epigenetic Age Ratio
Change in PBMC Gene Expression

Arms and interventions

Postbiotic SupplementationExperimental

Participants assigned to this arm received one capsule daily containing 100 mg of a postbiotic preparation composed of inactivated Lacticaseibacillus paracasei NPB01 and Lacticaseibacillus rhamnosus GG (1 × 10¹⁰ CFU equivalents) for 12 weeks.

PlaceboPlacebo comparator

Participants assigned to this arm received one placebo capsule daily without the postbiotic preparation for 12 weeks. The placebo capsules had organoleptic characteristics identical to those of the active supplement to maintain participant blinding.

Dietary supplements: Postbiotic Supplement, Placebo

Sites

1 site in 1 country

  • University of Naples Federico IINaples, Naples, Italy